Week 3 Flashcards

1
Q

Type I Hypersensitivity

A
  • IgE mediated
  • Onset within 1 hour
  • Ie) anaphylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Type II Hypersensitivity

A
  • IgG/IgM or cytotoxic mediated
  • Onset hours to days
  • Ie) hemolytic anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Type III Hypersensitivity

A
  • Immune complex mediated
  • 1-3 weeks
  • Ie) serum sickness or SLE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Type IV

A
  • T cell mediated
  • Onset days to weeks
  • Ie) rash or SJS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Th 1 Cell-Mediated Allergens

A
  • Contacted materials
  • Plant leaves
  • Industrial products made from plants
  • Synthetic chemicals in industrial products
  • Metals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

IgE-Mediated Allergen

A
  • Proteins
  • Foods
  • Plant pollens
  • Drugs
  • Insect products
  • Mold spores
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Atopic

A
  • Genetic tendency to develop allergic disease
  • Associated with heightened immune response to common allergens
  • Inhaled/food allergens
  • 1 atopic condition = more likely to develop another
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Common Atopic Conditions

A
  • Atopic asthma
  • Allergic eczema
  • Hay fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Allergy March

A
  • Natural history of atopic manifestation
  • IgE antibody responses clinical symptoms persist over years/decades
  • Spontaneously omit with age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

First Exposure (Type I Reaction)

A
  • Called sensitization
  • Produce IgE Abs to the allergen
  • Symptoms mild
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Re-Exposure (Type I Reaction)

A
  • Allergen binds IgE
  • Activates mast cell
  • Releases histamine & cytokines
  • Allergic reaction - more severe reaction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

First Exposure Process (Type I Reaction)

A
  1. Antigen presenting cell phagocytizes & processes antigen
  2. APC presents antigenic determinant to T cell
  3. IL-4 from T cell stimulates B cell
  4. B cell becomes plasma cell - secrete IgE
  5. IgE binds to mast cells, basophils, eosinophils
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Upper Resp Tract Allergies

A
  • Overproduction of mucus, sneezing, nasal congestion
  • Rhinitis (hay fever)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Lower Resp Tract Allergies

A
  • Bronchial smooth muscle contraction
  • Asthma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Skin Allergen

A
  • Local inflammation
  • Urticaria - hives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Bloodstream Allergen

A
  • Systemic inflammation
  • Anaphylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

GI Allergen Ingestion

A
  • Intestinal smooth muscle contraction - gastroenteritis (V/D)
  • Systemic inflammation - allergen enters blood if it is rapidly absorbed - anaphylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Anaphylaxis

A
  • Medical emergency
  • Life-threatening allergic reaction
  • Injected directly into blood/rapid absorption
  • Level of severity depends on level of previous sensitization
  • Food allergies most common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Anaphylactic Shock

A
  • Fast/slow HR
  • Low BP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Epinephrine

A
  • Temporary control of anaphylaxis
  • Rapidly increased BP
  • Causes vasoconstriction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Anaphylaxis Diagnosis

A
  • Increased serum IgE levels
  • Biopsy - GI related intolerances
  • Skin prick/patch test
  • Allergens show local inflammation at injection site when person is allergic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Desensitization Therapy

A
  • Allergy shots - gradually increase dose
  • Divert immune response from IgE tp IgG
  • Different route of entry for allergen
  • Long term treatment to decrease symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Desensitization Risk

A
  • Reactions possible
  • Mild (local) few hours of injection
  • Systemic reactions - 30 mins of injection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Type II Hypersensitivity Reaction

A
  • Opsonization & phagocytosis
  • Antibody dependent cellular cytotoxicity
  • Complement activation
  • Mediated by IgG or IgM antibodies
25
Q

Cellular Cytotoxicity Process

A

IgG binds to surface antigen on infected cell NK then kill infected cell

26
Q

Complement Activation Process

A
  1. IgG binds to complement
  2. Activating cell causing lysis
  3. Recruitment of neutrophils & monocytes
  4. Causing inflammation & tissue damage
27
Q

Rh Factor

A
  • Protein on red blood cells
  • Inherited
  • Most people Rh+
28
Q

Rh Incompatibility

A
  • Condition during pregnancy
  • Rh+ father & Rh- mother
  • Blood from baby (Rh+) crosses into blood stream from mom
  • Mother creates Rh antibodies
  • Antibodies don’t usually cause issues during 1st pregnancy
  • More likely to cause problems in later pregnancies
  • Rh antibodies cross placenta & damage fetal RBCs
  • Leads to hemolytic anemia in baby
29
Q

RohGAM Injection

A
  • Given to pregnant women Rh-
  • Immunoglobulin to prevent antibody formation against baby’s foreign antigen
30
Q

Type III Hypersensitivity

A
  • Immune complex mediated
  • Mediated by formation insoluble antigen antibody complex
  • Activate complement system
  • Produce localized inflammation
  • Produces damage when in contact in vessel lining/deposited in tissue
  • Once deposited immune complexes illicit inflammatory response by activating complement
  • Responsible for vasculitis, kidney damage
31
Q

Type III Process

A
  1. Immune complexes deposited in wall of blood vessel
  2. Presence of immune complexes activates complement & attracts inflammatory cells (neutrophils)
  3. Enzymes release from neutrophils cause damage to endothelial cells from basement membrane
32
Q

Post Streptococcal Glomerulonephritis

A
  • Following streptococcal infection - group A (neptorgentic)
  • Impacts nephriti and small vessels of kidneys
  • Children 1-2 weeks after sore/strep throat, skin infection by strep impetigo
  • Causes infiltration of leukocytes & proliferation of other cells in glomerulus
  • Impairs capillary perfusion & glomerular filtration rate
33
Q

Post Streptococcal Glomerulonephritis Complications

A
  • Renal failure
  • Acid/base imbalance
  • Electrolyte Abnormalities
  • Fluid volume overload
  • Edema
  • Hypertension
34
Q

Post Streptococcal Glomerulonephritis Symptom Triad

A
  • Hematuria (tea coloured)
  • Edema
  • Hypertension
35
Q

Type IV Hypersensitivity

A
  • Cell-mediated
  • Delayed type hypersensitivity
  • T-cells activated by antigens
  • Occurs over 24-72hrs
  • Previous exposure to antigen to mount immune response to 2nd exposure
36
Q

Type IV Process

A
  1. Antigen introduced into subcutaneous tissue & processed by local antigen presenting cells
  2. Th1 effector cell recognizes antigen & release cytokines which act on vascular endothelium
  3. Recruitment of T cells, phagocytes, fluid, protein to site of antigen injection causes visible lesion
37
Q

TB Skin Test

A
  • Inactivated TB injected under the skin
  • Previous exposure - develop local redness in 8-12 hrs
  • Perivascular accumulation of CD4+ T cells, macrophages
  • Local secretion of cytokines = increased vascular permeability
  • Causing local redness & swelling
  • Measure reaction of induration not surrounding redness
38
Q

Normal Immune Response

A
  1. Invader (virus) enters body
  2. Lymphocytes create antibodies to fight invader
39
Q

Autoimmune Disease

A
  • Immune system creates antibodies that attack own cells
  • Breakdown in immune system to differentiate between self & non-self
  • Results in destruction of own cells/organs
  • 5-10% of population
  • Chronic with relapses & remissions
  • Damage is progressive
40
Q

Causes of Autoimmune Disease

A
  • Foreign substance resembles bodily substance
  • Normal body cells become altered
  • Lymphocytes malfunction & make abnormal antibodies
41
Q

Self Antigen or Autoantigen

A

Antigen expressed on your own cells

42
Q

Autoreactive Cells

A
  • T/B cells that bind to a self antigen
  • BAD
43
Q

Autoantibody

A
  • Antibody that binds to a self antigen
  • BAD
44
Q

Self Tolerance

A

Ability of the immune system to recognize self-produced antigens as a non-threat while appropriately mounting a response to foreign substances

45
Q

Central Tolerance

A
  • Eliminating any developing T/B lymphocytes that are autoreactive
    Thymus - T cells
    Bone marrow - B cells
46
Q

Peripheral Tolerance

A

Immunological tolerance developed after autoreactive T&B cells mature and enter periphery

47
Q

Autoimmunity

A
  • Result of loss of self-tolerance
  • Inheritance of susceptibility genes
  • Gender - women 5:1
  • Trigger event: alter immune state
48
Q

Trigger Event

A

Microbe shares immunological epitope with host

49
Q

Environmental Factors

A

Promote activation of self-reactive lymphocytes

50
Q

Autoimmunity Classification

A

Area of overlap of organ specific & systemic characteristics

51
Q

Organ Specific

A
  • Response targets antigen present in specific organ
  • Graves disease
  • Hashimoto’s thyroiditis
  • T1D
  • MS
52
Q

Systemic Characteristics

A
  • Antigen present at many different sites - involve multiple organs
  • Rheumatoid arthritis
  • Systemic scleroderma
  • Systemic lupus erythematosus (SLE)
53
Q

Graves Disease - Hyperthyroidism

A
  • Immune system attacks thyroid - too much thyroid hormone produced
  • Produce TSH receptor antibodies (TSI)
  • Abs bind to TSH receptor
  • Constant over secretion of T3, T4
54
Q

Healthy Thyroid

A
  • TSH secreted by pituitary
  • TSH binds to TSH receptor on thyroid cells
  • Stimulates release of thyroid hormones (T3, T4)
  • Inhibit TSH production
55
Q

Insulin-Dependent Diabetes Mellitus - Type I Diabetes

A
  • Chronic autoimmune destruction of insulin producing beta cells in pancreas
  • Autoreactive CTLs kill insulin-producing B-cells in pancreas
  • Results in reduced insulin production, hyperglycemia
  • Unknown what triggers inflammation in the pancreas
  • Clusters in spring & fall
56
Q

Multiple Sclerosis - MS

A
  • Myelin sheath of nerve fibers in brain & spinal cord destroyed by autoreactive T cells
  • Disrupts electrical signals & causes paralysis
  • Unclear what triggers myelin damage & CNS inflammation
  • Inflammatory process
57
Q

Autoimmune Disease Treatments

A
  • Treatment focus on mechanism
  • Immunosuppression
  • Plasmapheresis
  • Block MHC with similar peptide
  • Use antibodies that block B cells/T cells
  • Disease specific treatments
58
Q

Immunosuppression

A
  • NSAIDS
  • Prednisone
  • Cyclosporin A
59
Q

Plasmapheresis

A
  • Remove antibodies
  • Temporary fix